Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Amortization - Intangibles (2022 - 2024)

Historic Amortization - Intangibles for PAVmed (PAVM) over the last 3 years, with Q2 2024 value amounting to $105000.0.

  • PAVmed's Amortization - Intangibles fell 7920.79% to $105000.0 in Q2 2024 from the same period last year, while for Dec 2024 it was $982000.0, marking a year-over-year decrease of 5138.61%. This contributed to the annual value of $559000.0 for FY2024, which is 7234.04% down from last year.
  • Per PAVmed's latest filing, its Amortization - Intangibles stood at $105000.0 for Q2 2024, which was down 7920.79% from $372000.0 recorded in Q1 2024.
  • PAVmed's 5-year Amortization - Intangibles high stood at $650000.0 for Q2 2022, and its period low was $105000.0 during Q2 2024.
  • For the 3-year period, PAVmed's Amortization - Intangibles averaged around $428100.0, with its median value being $505000.0 (2022).
  • Its Amortization - Intangibles has fluctuated over the past 5 years, first surged by 31056.91% in 2023, then plummeted by 7920.79% in 2024.
  • Quarter analysis of 3 years shows PAVmed's Amortization - Intangibles stood at $506000.0 in 2022, then decreased by 0.2% to $505000.0 in 2023, then tumbled by 79.21% to $105000.0 in 2024.
  • Its Amortization - Intangibles was $105000.0 in Q2 2024, compared to $372000.0 in Q1 2024 and $505000.0 in Q4 2023.